Korio, Inc. raised an undisclosed amount in a Series A funding led by BIP Ventures to accelerate the growth of its innovative Randomization & Trial Supply Management platform.
Korio, Inc. raised an undisclosed amount in a Series A funding led by BIP Ventures to accelerate the growth of its innovative Randomization & Trial Supply Management platform.
09/10/24, 12:37 PM
Location
doylestownIndustry
information technology
Round Type
series a
Investors
Boston Millennia Partners, Excelerate Health Ventures, Bip Ventures
Korio, Inc. successfully completed its Series A funding round led by BIP Ventures, with participation from existing investors. This investment highlights strong customer demand for Korio's flexible and quality-focused RTSM platform.
Company Info
Location
320 e. state street
doylestown, pennsylvania, united states
Additional Info
Korio is the industry’s leading compliance-centric Randomization & Trial Supply Management (RTSM) platform. Reflecting decades of hands-on experience across thousands of trial designs, Korio enables once aspirational goals around feature reusability, process repeatability, system performance, and overall system quality by embedding the latest RTSM design intelligence into our solution. Our intuitive approach to RTSM setup and management through a regulatory lens ensures audit-readiness and a predictable GxP compliant outcome on every clinical trial.